Patents by Inventor Christophe Przybylski

Christophe Przybylski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DMAE as sole agent for the treatment of mild cognitive impairment
    Patent number: 8207218
    Abstract: The present invention relates to the use, as sole active ingredient, of dimethylaminoethanol (DMAE) in free form or in the form of salts or of esters and also of hydrates and solvates thereof, for the manufacture of a medicament for use in the treatment of a non-dementia mild cognitive impairment characterized by an amnestic syndrome of hippocampal type.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: June 26, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Pierre Fabre, Christophe Przybylski, Bruno Dubois
  • Use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic M, M, and Mreceptors
    Patent number: 8143245
    Abstract: This invention relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine as well as its pharmaceutically acceptable salts for the preparation of a drug having the particularity of treating or preventing urinary incontinence, by local and/or oral route.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: March 27, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Clerc, Jacky Tisne-Versailles, Christophe Przybylski
  • EMOLLIENT COMPOSITION
    Publication number: 20110071226
    Abstract: The invention relates to an emollient composition for topical use that comprises a combination of glycerol, Vaseline and liquid paraffin as an active principle, in the form of an oil-in-water or water-in-oil emulsion. The invention also relates to: the use thereof for preparing a drug for treating dry skin conditions associated with certain dermatoses such as atopic dermatitis, ichthyosis conditions and psoriasis; the use thereof for preparing a drug for treating small superficial burns; and the use thereof for preparing a drug for preventing and/or treating and/or reducing the frequency and intensity of eczema attacks observed in patients suffering from atopic dermatitis.
    Type: Application
    Filed: May 18, 2009
    Publication date: March 24, 2011
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Pierre Fabre, Christophe Przybylski, Jean-François Cordoliani, Marion Kopec
  • MEQUITAZINE FOR TREATING OR PREVENTING PATHOLOGIES INVOLVING HISTAMINE H4 RECEPTORS
    Publication number: 20100273752
    Abstract: The present application relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or 10-[(3R,3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, or a pharmaceutically acceptable salt thereof, to prepare a drug to prevent or treat pathologies involving histamine H4 receptor.
    Type: Application
    Filed: December 4, 2008
    Publication date: October 28, 2010
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Thierry Clerc, Christophe Przybylski, Jacky Tisne-Versailles, Didier Cussac
  • USE OF 10-[(3R)-1-AZABICYCLO[2.2.2]OCT-3-YLMETHYL]-10H-PHENOTHIAZINE FOR THE PREPARATION OF A DRUG HAVING A SELECTIVE INHIBITION OF MUSCARINIC M1, M2, AND M3 RECEPTORS
    Publication number: 20100063276
    Abstract: This invention relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine as well as its pharmaceutically acceptable salts for the preparation of a drug having the particularity of treating or preventing urinary incontinence, by local and/or oral route.
    Type: Application
    Filed: December 26, 2007
    Publication date: March 11, 2010
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Thierry Clerc, Jacky Tisne-Versailles, Christophe Przybylski
  • Treatment of Vertigo with Acetyl-L-Leucine
    Publication number: 20090318555
    Abstract: The use of acetyl-L-leucine and the pharmaceutically acceptable salts of same for the manufacture of a medicament for the treatment of vertigo and other balance disorders. Advantageously, the acetyl-L-leucine is a 100% mixture.
    Type: Application
    Filed: September 13, 2007
    Publication date: December 24, 2009
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Pierre Fabre, Christophe Przybylski, Anne-Sophie Saurel
  • Use of Acetyl-Leucine for Preparing a Drug for Treating Balance Disorders
    Publication number: 20080108702
    Abstract: The invention concerns the use of acetyl-leucine for preparing a drug for treating acute deafferentiation in patients whose vestibular deficit is less than (88%), advantageously less than (75%) to caloric tests.
    Type: Application
    Filed: March 17, 2006
    Publication date: May 8, 2008
    Inventor: Christophe Przybylski